Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 9651-9700 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05280470
Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
PHASE2Active, not recruiting
187 participants
Started: Mar 9, 2022 · Completed: Nov 15, 2025
1 condition2 sponsors58 locations
NCT05243888
Efficacy of Strategies Involving Self-sampling to Reach Women Not Participating in Regular Cervical Cancer Screening
NAActive, not recruiting
15,000 participants
Started: Mar 9, 2022 · Completed: Mar 31, 2025
1 condition5 sponsors1 location
NCT05304819
PMCF Study of the AchilloCordPLUS System Implant Set for Acute Achilles Tendon Repair
N/AActive, not recruiting
19 participants
Started: Mar 9, 2022 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05040841
Supporting Sustained HIV Treatment Adherence After Initiation
NAActive, not recruiting
534 participants
Started: Mar 9, 2022 · Completed: May 31, 2026
2 conditions5 sponsors3 locations
NCT05057637
The Impact of Optical Coherence Tomography on the Endovascular Treatment Planning of Femoropopliteal Disease
N/AActive, not recruiting
25 participants
Started: Mar 9, 2022 · Completed: Oct 31, 2025
1 condition3 sponsors1 location
NCT04950608
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
PHASE2Active, not recruiting
15 participants
Started: Mar 9, 2022 · Completed: Dec 31, 2025
8 conditions10 sponsors1 location
NCT06356038
Phrenic Nerve Infiltration: Pulmonary Expansion and Pain Control
NAActive, not recruiting
66 participants
Started: Mar 9, 2022 · Completed: Jan 2, 2025
2 conditions1 sponsor1 location
NCT05251402
Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern
PHASE2/PHASE3Active, not recruiting
323 participants
Started: Mar 9, 2022 · Completed: Sep 1, 2026
1 condition6 sponsors2 locations
NCT06302660
Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors
N/AActive, not recruiting
100 participants
Started: Mar 9, 2022 · Completed: Dec 1, 2025
3 conditions4 sponsors3 locations
NCT05264662
Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women
PHASE4Active, not recruiting
511 participants
Started: Mar 8, 2022 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05210621
LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB
PHASE3Active, not recruiting
72 participants
Started: Mar 8, 2022 · Completed: Feb 24, 2029
1 condition1 sponsor15 locations
NCT05490602
Comparison Study in Different Sutures Techniques in Reduction of Known Abdominoplasty Complications and Improving Patients' Post-operative Outcomes
N/AActive, not recruiting
100 participants
Started: Mar 8, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06015230
Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE
PHASE1/PHASE2Active, not recruiting
136 participants
Started: Mar 8, 2022 · Completed: Oct 4, 2028
1 condition1 sponsor1 location
NCT05064878
A Study to Investigate the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder
PHASE3Active, not recruiting
87 participants
Started: Mar 8, 2022 · Completed: Nov 8, 2027
4 conditions1 sponsor46 locations
NCT05131828
CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy
PHASE2Active, not recruiting
70 participants
Started: Mar 8, 2022 · Completed: May 31, 2025
1 condition2 sponsors1 location
NCT04881032
AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma
PHASE1/PHASE2Active, not recruiting
66 participants
Started: Mar 7, 2022 · Completed: Mar 31, 2027
1 condition2 sponsors9 locations
NCT05302050
A Cognitive Behavioral Digital Therapeutic InterventiON for Glycemic Control in Type 2 Diabetes Mellitus
NAActive, not recruiting
500 participants
Started: Mar 7, 2022 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT05183737
Effects of Microencapsulated Propolis and Turmeric in Patients With Chronic Kidney Disease
NAActive, not recruiting
34 participants
Started: Mar 7, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05132582
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
PHASE3Active, not recruiting
654 participants
Started: Mar 7, 2022 · Completed: Sep 28, 2027
1 condition1 sponsor295 locations
NCT05343403
Parental Participation on the Neonatal Ward - the neoPARTNER Study
N/AActive, not recruiting
613 participants
Started: Mar 7, 2022 · Completed: Mar 1, 2025
15 conditions2 sponsors10 locations
NCT05098470
Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity
PHASE3Active, not recruiting
100 participants
Started: Mar 7, 2022 · Completed: Jul 29, 2026
1 condition2 sponsors2 locations
NCT05118906
Pilot Study on BP1.4979 Effect on Binge Eating Disorders
PHASE2Active, not recruiting
66 participants
Started: Mar 7, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05250908
INTIBIA Pivotal Study
NAActive, not recruiting
208 participants
Started: Mar 7, 2022 · Completed: Jun 27, 2026
6 conditions1 sponsor22 locations
NCT05988450
Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation
NAActive, not recruiting
125 participants
Started: Mar 7, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05052801
Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
PHASE3Active, not recruiting
547 participants
Started: Mar 7, 2022 · Completed: Jun 20, 2026
2 conditions2 sponsors300 locations
NCT05259982
Vital Root-resective Therapy in Furcation-involved Maxillary Molars
NAActive, not recruiting
10 participants
Started: Mar 4, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT06075680
Effect of Periodontal Treatment on Inflammasome Proteins in Periodontal Diseases
NAActive, not recruiting
45 participants
Started: Mar 4, 2022 · Completed: Nov 30, 2023
3 conditions1 sponsor1 location
NCT05239845
Evaluating the Effects of Prebiotics on Sleep, the Gut Microbiome, Cognition, Immune Function and Stress
NAActive, not recruiting
68 participants
Started: Mar 3, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT04978584
Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study
PHASE2Active, not recruiting
62 participants
Started: Mar 3, 2022 · Completed: Jan 16, 2027
1 condition1 sponsor1 location
NCT05201014
Cancer Survivor Cardiomyopathy Detection
N/AActive, not recruiting
112 participants
Started: Mar 3, 2022 · Completed: Sep 20, 2026
2 conditions2 sponsors1 location
NCT05064358
Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma
PHASE2Active, not recruiting
177 participants
Started: Mar 3, 2022 · Completed: Jan 30, 2026
1 condition1 sponsor88 locations
NCT05294120
A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma
PHASE2Active, not recruiting
38 participants
Started: Mar 3, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors7 locations
NCT05274022
Rehabilitation Strategies to Improve Outcomes For Patients With a Lower Extremity Fracture
NAActive, not recruiting
66 participants
Started: Mar 3, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT05064462
TTV Viral Load in Heart Transplant Recipients
N/AActive, not recruiting
60 participants
Started: Mar 3, 2022 · Completed: Mar 3, 2024
3 conditions2 sponsors3 locations
NCT05153226
GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG
PHASE3Active, not recruiting
640 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2026
6 conditions1 sponsor23 locations
NCT05236660
Personalised Assistive Devices Approach for Diabetic Foot Ulcer Prevention
NAActive, not recruiting
126 participants
Started: Mar 2, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors5 locations
NCT04865679
Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends
NAActive, not recruiting
15 participants
Started: Mar 2, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor2 locations
NCT05139381
Study for Children & Adolescent With Severe Asthma With an Eosinophilic Phenotype Treated With Mepolizumab
N/AActive, not recruiting
148 participants
Started: Mar 2, 2022 · Completed: Mar 12, 2026
1 condition1 sponsor1 location
NCT04742751
An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer
PHASE2Active, not recruiting
96 participants
Started: Mar 2, 2022 · Completed: Nov 30, 2026
2 conditions4 sponsors1 location
NCT05268562
Ketamine and Kidney Injury in Cardiac Surgery
PHASE4Active, not recruiting
200 participants
Started: Mar 2, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05388123
Low Dose Vemurafenib and Rituximab in Hairy Cell Leukemia
PHASE2Active, not recruiting
20 participants
Started: Mar 2, 2022 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT05333679
Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support (UTRA Study)
NAActive, not recruiting
200 participants
Started: Mar 2, 2022 · Completed: Jun 30, 2025
1 condition4 sponsors1 location
NCT05092412
Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC
PHASE2Active, not recruiting
30 participants
Started: Mar 2, 2022 · Completed: Jun 30, 2025
3 conditions2 sponsors3 locations
NCT04962477
Understanding Host-pathogen Interaction in the Respiratory Mucosa During Pregnancy
N/AActive, not recruiting
30 participants
Started: Mar 2, 2022 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT05057715
huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer
PHASE1Active, not recruiting
13 participants
Started: Mar 2, 2022 · Completed: Sep 30, 2038
2 conditions2 sponsors1 location
NCT05823766
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
N/AActive, not recruiting
300 participants
Started: Mar 1, 2022 · Completed: Feb 28, 2027
2 conditions2 sponsors9 locations
NCT05500599
Effects on Recovery of Children of Intravenous Formulation of Fentanyl Citrate and Midazolam Orally for Premedication
NAActive, not recruiting
60 participants
Started: Mar 1, 2022 · Completed: Aug 28, 2025
1 condition1 sponsor1 location
NCT05148871
Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine
PHASE2/PHASE3Active, not recruiting
200 participants
Started: Mar 1, 2022 · Completed: Oct 6, 2024
1 condition3 sponsors1 location
NCT05301478
Patient Specific 3D Printed Diabetic Insoles to Reduce Plantar Pressure
NAActive, not recruiting
25 participants
Started: Mar 1, 2022 · Completed: Mar 30, 2026
1 condition1 sponsor1 location
NCT05579717
Examining the Effectiveness of EAL
NAActive, not recruiting
40 participants
Started: Mar 1, 2022 · Completed: Aug 31, 2025
1 condition3 sponsors1 location